## Abstract Catalytic reductive dehalogenation of 5‐bromo‐6‐azauracil with carrier‐free tritium led to 6‐azauracil‐5‐^3^ H of a molar activity of 19.0 Ci/mmole. The reaction conditions for the catalytic reductive dehalogenation were examined in tracer experiments. Microbial transformation was used
Preparation of 5-fluorouracil-6-3H of high specific activity
✍ Scribed by Jíří Filip; František Vyšata
- Publisher
- John Wiley and Sons
- Year
- 1969
- Tongue
- French
- Weight
- 448 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Isotopic exchange of hydrogen in a system of s~lvent-water-~H was used to prepare 5-Juoroorotic a ~i d -~H ( G ) which was decarboxylated and the hydrogen-3H removed from labile bonds to yield 5'-Juorouracil-6-3H. It was found in tracer experiments that a suitable solvent for the isotopic exchange of hydrogen was anhydrous dimethylformamide of dioxane. Water-3H of high specijic activity was prepared in these solvents by reduction of PtOz to Pt using carrierfree tritium. The specific activity of 5-JEuoro~raci1-6-~H was of the order of Cilmmole, the radiochemical purity was better than 96 %.
📜 SIMILAR VOLUMES
The preparation of the 61-specific ligand 7-benzylidenenaltrexone (BNTX), labeled with tritium at high specific activity (14.4 Ciimmol) was prepared in 33% yield and >98% purity by the aldol condensation of high specific activity [15,1 6-3H]naltrexone with benzaldehyde at high dilution.
High-specific-activity D-[3-3H]pantothenic acid (5 Ci/mmol) was prepared from commercially available beta-[3-3H]alanine employing Escherichia coli strain DV1 (panD2 pan F1). This strain is defective in beta-alanine synthesis and pantothenate uptake, and under appropriate growth conditions converted
## Abstract Lithium borotritide reduction of α‐ionylidene‐acetaldehyde (5) followed by manganese dioxide oxidation provided the tritiated aldehyde (9) which retainad over 95% of the label. On treatment with the ylide derived from ethyl 4‐chloro‐3‐methylcrotonate, ethyl α‐retinoate‐11‐^3^H (14) was